Event-Free Survival and intravascular ultrasound (IVUS) measures 1.5 years [clinicaltrials_resource:7f12674170648ce56f319c90af1a1fae]
Event-Free Survival (EFS) is a composite of: the development of hemodynamic compromise with rejection, allograft dysfunction (hemodynamic compromise without histologically confirmed rejection), death from any cause, or re-transplantation.
IVUS co-primary endpoint: maximal intimal thickness of the coronary arteries from baseline (measured at 6 weeks ± 30 days) to month 12 of ≥0.5mm, as measured by IVUS.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Event-Free Survival and intravascular ultrasound (IVUS) measures 1.5 years [clinicaltrials_resource:7f12674170648ce56f319c90af1a1fae]
Event-Free Survival (EFS) is a composite of: the development of hemodynamic compromise with rejection, allograft dysfunction (hemodynamic compromise without histologically confirmed rejection), death from any cause, or re-transplantation.
IVUS co-primary endpoint: maximal intimal thickness of the coronary arteries from baseline (measured at 6 weeks ± 30 days) to month 12 of ≥0.5mm, as measured by IVUS.
Bio2RDF identifier
7f12674170648ce56f319c90af1a1fae
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:7f12674170648ce56f319c90af1a1fae
measure [clinicaltrials_vocabulary:measure]
Event-Free Survival and intravascular ultrasound (IVUS) measures
time frame [clinicaltrials_vocabulary:time-frame]
description
Event-Free Survival (EFS) is a ...... f ≥0.5mm, as measured by IVUS.
identifier
clinicaltrials_resource:7f12674170648ce56f319c90af1a1fae
title
Event-Free Survival and intravascular ultrasound (IVUS) measures 1.5 years
@en
type
label
Event-Free Survival and intrav ...... 2674170648ce56f319c90af1a1fae]
@en